Dexterra Group Inc. Announces Results for Q4 and Year Ended December 31, 2025
Rhea-AI Summary
Dexterra Group (OTC: HZNOF) reported 2025 results: revenue $1.041B (+3.8% vs 2024) and Adjusted EBITDA $122.8M (+14.3%). Q4 revenue was $271.0M (+9.4%) and Q4 Adjusted EBITDA $32.6M (+22%). Free Cash Flow was $60.3M with FCF conversion of 49%.
Key 2025 moves: 40% investment in Pleasant Valley Corporation for $84.0M, acquisition of Right Choice for $69.0M, NCIB purchases of 1.48M shares, and dividend of $0.375 declared with Q1 2026 dividend $0.10 payable April 15, 2026.
Positive
- Revenue of $1.041B in 2025 (+3.8% YoY)
- Adjusted EBITDA $122.8M (+14.3% YoY)
- Q4 revenue growth +9.4% year-over-year
- Strategic investments: $84M PVC stake and $69M Right Choice
- Dividend maintained and increased annual target to $0.40 earlier
Negative
- Free Cash Flow declined to $60.3M (FCF conversion 49%)
- Net debt rose to $199.7M (up from $67.9M in Q4 2024)
- Asset Based Services revenue down 9.9% for 2025
Toronto, Ontario--(Newsfile Corp. - March 3, 2026) - Dexterra Group Inc. (TSX: DXT)
Highlights
Dexterra delivered strong results for 2025 with revenue of
$1.04 billion , an increase of3.8% compared to$1.0 billion in 2024, driven by strong Support Services revenue growth from new sales, strong market activity levels, and the acquisition of Right Choice Camps and Catering Ltd. ("Right Choice"), partially offset by lower ABS revenue. For Q4 2025, Dexterra generated consolidated revenue of$271.0 million , an increase of9.4% , compared to Q4 2024, primarily driven by Support Services revenue growth, including strong camp occupancy levels and contribution from Right Choice.Adjusted EBITDA for 2025 was
$122.8 million , an increase of14.3% compared to 2024 as a result of strong workforce accommodation occupancy and contributions of$2.8 million and$7.2 million from the investments in Pleasant Valley Corporation ("PVC") and Right Choice, respectively. Adjusted EBITDA for Q4 2025 was$32.6 million , an increase of22% compared to Q4 2024 driven primarily by the factors mentioned above and contributions from PVC and Right Choice.Free Cash Flow ("FCF") was
$60.3 million for the year ended December 31, 2025, compared to$74.7 million in 2024, representing Adjusted EBITDA conversion to FCF of49% compared to70% in the prior year. FCF in 2025 was impacted by the delayed receipt of a customer receivable funded by the Canadian federal government of which$11.2 million was collected subsequent to year end.For the three months and year ended December 31, 2025, net earnings were
$7.4 million and$40.8 million , respectively, compared to$6.9 million and$20.1 million , respectively in 2024. Earnings per share was$0.65 in 2025 compared to$0.31 in 2024. 2024 results included a loss from discontinued operations of$17.4 million . Our operations delivered a return on equity in 2025 of15% .Dexterra made two strategic investments in 2025 including a
40% stake in privately owned, US-based, facilities management provider PVC for$84.0 million on July 31, 2025, including an option to acquire the remaining60% as early as Q3 2027, and, on August 31, 2025, Dexterra closed the acquisition of Right Choice, a workforce accommodation provider with operations in the strategic Montney / Duvernay gas region in Western Canada, for$69.0 million .In connection with the ongoing Normal Course Issuer Bid ("NCIB"), Dexterra purchased and cancelled 1,483,900 common shares in 2025 at a weighted average price of
$7.88 per share for total consideration of$11.7 million .In Q3 2025, the Board of Directors approved a
14% increase in the annual dividend to$0.40 per share. Dexterra declared$0.37 5 per share in dividends for 2025 and declared a Q1 2026 dividend of$0.10 per share, payable on April 15, 2026 to shareholders of record as at March 31, 2026.
This news release contains certain measures and ratios, such as Adjusted EBITDA, Adjusted EBITDA as a percentage of revenue, Return on Equity, and Free Cash Flow that do not have any standardized meaning as prescribed by GAAP and, therefore, are considered non-GAAP measures. The method of calculating these measures may differ from other entities and accordingly, may not be comparable to measures used by other entities. See "Non-GAAP measures" and "Reconciliation of Non-GAAP measures" of Dexterra's MD&A for the three months and years ended December 31, 2025 and 2024 details which is incorporated by reference herein.
Fourth Quarter and Annual Financial Summary
| Three months ended December 31, | Years ended December 31, | |||||||||||
| (000's except per share amounts) | 2025 | 2024 | 2025 | 2024 | ||||||||
| Revenue | $ | 270,951 | $ | 247,758 | $ | 1,041,250 | $ | 1,003,027 | ||||
| Adjusted EBITDA(1) | 32,574 | 26,558 | 122,815 | 107,438 | ||||||||
| Adjusted EBITDA as a % of revenue(1) | ||||||||||||
| Net earnings(2)(3) | 7,416 | 6,915 | 40,801 | 20,093 | ||||||||
| Net earnings per share, basic and diluted(3) | 0.12 | 0.11 | 0.65 | 0.31 | ||||||||
| Total assets | 720,675 | 524,890 | 720,675 | 524,890 | ||||||||
| Total loans and borrowings ("Net Debt") | 199,717 | 67,859 | 199,717 | 67,859 | ||||||||
| Free Cash Flow(1) | 24,549 | 52,701 | 60,266 | 74,680 | ||||||||
(1) Please refer to the "Non-GAAP measures" section for the definition of Adjusted EBITDA, Adjusted EBITDA as a percentage of revenue and Free Cash Flow and to the "Reconciliation of non-GAAP measures" section for the related calculations.
(2) Acquisition costs in pre-tax earnings for the three months and year ended December 31, 2025, were
(3) Net earnings for the three months and year ended December 31, 2024 includes a net loss from discontinued operations, net of income taxes, of
Fourth Quarter and Annual Operational Analysis
| Three months ended December 31, | Years ended December 31, | |||||||||||
| (000's) | 2025 | 2024 | 2025 | 2024 | ||||||||
| Revenue: | ||||||||||||
| Support Services | $ | 230,582 | $ | 206,472 | $ | 868,306 | $ | 811,180 | ||||
| Asset Based Services | 40,369 | 41,286 | 172,944 | 191,847 | ||||||||
| Total Revenue | $ | 270,951 | $ | 247,758 | $ | 1,041,250 | $ | 1,003,027 | ||||
| Adjusted EBITDA: | ||||||||||||
| Support Services | $ | 23,874 | $ | 18,209 | $ | 87,734 | $ | 74,133 | ||||
| Asset Based Services | 15,095 | 13,896 | 61,199 | 56,215 | ||||||||
| Corporate, Other and Inter-segment eliminations | (6,395 | ) | (5,547 | ) | (26,118 | ) | (22,910 | ) | ||||
| Total Adjusted EBITDA | $ | 32,574 | $ | 26,558 | $ | 122,815 | $ | 107,438 | ||||
| Adjusted EBITDA as a % of Revenue | ||||||||||||
| Support Services | 10.4 % | 8.8 % | 10.1 % | 9.1 % | ||||||||
| Asset Based Services | 37.4 % | 33.7 % | 35.4 % | 29.3 % | ||||||||
Support Services
Revenue for the year ended December 31, 2025 was
Adjusted EBITDA for the year ended December 31, 2025 was
For Q4 2025, Support Services revenues were
Asset Based Services
Revenue for the year ended December 31, 2025 was
Adjusted EBITDA for the year ended December 31, 2025 was
For Q4 2025, ABS revenues were
Liquidity and Capital Resources
Net Debt was
Additional Information
A copy of Dexterra's Consolidated Financial Statements ("Financial Statements") for the years ended December 31, 2025 and 2024 and related Management's Discussion and Analysis ("MD&A") have been filed with the Canadian Securities Regulatory authorities and are available on SEDAR at sedarplus.ca and Dexterra's website at dexterra.com. The Financial Statements have been prepared in accordance with International Financial Reporting Standards and the reporting currency is in Canadian dollars.
Conference Call
Dexterra will host a conference call and webcast to begin promptly at 8:30 a.m. Eastern Time on March 4, 2026 to discuss the 2025 year-end and fourth quarter results.
To access the conference call by telephone the conference call dial in number is 1-833-752-2807.
A live webcast of the conference call will be accessible on Dexterra's website at ir.dexterra.com/events-presentations by selecting the Q4 2025 Results webcast link. An archived recording of the conference call will be available approximately one hour after the completion of the call until April 4, 2026, by dialing 1- 855-669-9658, passcode 2946867.
About Dexterra
Dexterra employs more than 9,000 people, delivering a range of support services for the creation, management, and operation of infrastructure across Canada and the U.S.
Powered by people, Dexterra brings best-in-class regional expertise to every challenge and delivers innovative solutions, giving clients confidence in their day-to-day operations. Activities include a comprehensive range of integrated facilities management services, industry-leading workforce accommodation solutions and other support services for diverse clients in the public and private sectors.
For further information contact:
Denise Achonu, CFO
Head office: Airway Centre, 5925 Airport Rd., Suite 1000
Mississauga, Ontario L4V 1W1
Telephone: (905) 270-1964
You can also visit our website at dexterra.com
Reconciliation of non-GAAP measures
The following provides a reconciliation of non-GAAP measures to the nearest measure under GAAP for items presented throughout the news release:
Adjusted EBITDA
| Three months ended December 31, | Years ended December 31, | |||||||||||
| (000's) | 2025 | 2024 | 2025 | 2024 | ||||||||
| Net earnings from continuing operations | $ | 7,416 | $ | 7,584 | $ | 40,801 | $ | 37,540 | ||||
| Add: | ||||||||||||
| Share based compensation | 4,038 | 1,200 | 10,104 | 4,557 | ||||||||
| Depreciation & amortization | 12,123 | 9,612 | 42,343 | 35,205 | ||||||||
| Equity investment depreciation, amortization and income taxes | 2,212 | 87 | 2,839 | 974 | ||||||||
| Finance costs | 4,215 | 2,364 | 11,335 | 13,058 | ||||||||
| Loss (gain) on disposal of property, plant and equipment | (350 | ) | 15 | 237 | (354 | ) | ||||||
| Income tax expense | 2,253 | 5,696 | 13,888 | 16,097 | ||||||||
| Other(1) | 667 | - | 1,268 | 361 | ||||||||
| Adjusted EBITDA | $ | 32,574 | $ | 26,558 | $ | 122,815 | $ | 107,438 | ||||
(1) Other includes acquisition expenses for the three months and year ended December 31, 2025 related to the Right Choice acquisition, as well as expenses related to the CMI acquisition for the year ended December 31, 2024.
Free Cash Flow
| Three months ended December 31, | Years ended December 31, | |||||||||||
| (000's) | 2025 | 2024 | 2025 | 2024 | ||||||||
| Net cash flows from continuing operating activities | $ | 33,461 | $ | 58,150 | $ | 87,593 | $ | 96,481 | ||||
| Sustaining capital expenditures, net of proceeds from the sale of property, plant and equipment and intangible assets | (624 | ) | (1,424 | ) | (3,329 | ) | (2,754 | ) | ||||
| Finance costs paid | (4,910 | ) | (1,986 | ) | (13,341 | ) | (12,165 | ) | ||||
| Lease payments | (3,378 | ) | (2,039 | ) | (10,657 | ) | (6,882 | ) | ||||
| Free Cash Flow | $ | 24,549 | $ | 52,701 | $ | 60,266 | $ | 74,680 | ||||
Return on Equity
| Years ended December 31, | ||||||
| (000's) | 2025 | 2024 | ||||
| Net earnings from continuing operations | $ | 40,801 | $ | 37,540 | ||
| Average total shareholders' equity(1) | 281,504 | 282,984 | ||||
| Return on Equity (%) | 15 % | 13 % | ||||
(1) Average total shareholders' equity is calculated as the average of beginning total shareholders' equity and ending total shareholders' equity for the year.
Forward-Looking Information
Certain statements contained in this news release may constitute forward-looking information under applicable securities law. Forward-looking information may relate to Dexterra's future outlook and anticipated events, business, operations, financial performance, financial condition or results and, in some cases, can be identified by terminology such as "continue"; "forecast"; "may"; "will"; "project"; "could"; "should"; "expect"; "plan"; "anticipate"; "believe"; "outlook"; "target"; "intend"; "estimate"; "predict"; "might"; "potential"; "continue"; "foresee"; "ensure" or other similar expressions concerning matters that are not historical facts. In particular, statements regarding Dexterra's future operating results and economic performance, including return on equity and Adjusted EBITDA margins; capital allocation priorities, acquisition strategy; its capital light model, market and inflationary environment expectations, asset utilization, camp occupancy levels, its leverage, FCF, wildfire activity expectations, expected benefits from the Right Choice and PVC acquisitions, investments in technology, US tariff impacts, and its objectives and strategies are forward-looking statements. These statements are based on certain factors and assumptions, including expected growth, market recovery, results of operations, performance and business prospects and opportunities regarding Dexterra. While management considers these assumptions to be reasonable based on information currently available to Dexterra, they may prove to be incorrect. Forward-looking information is also subject to certain known and unknown risks, uncertainties and other factors that could cause Dexterra's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information, including, but not limited to: the ability to retain clients, renew existing contracts and obtain new business; an outbreak of contagious disease that could disrupt its business; the highly competitive nature of the industries in which Dexterra operates; outsourcing of services trends; reliance on suppliers and subcontractors; cost inflation; US tariff impacts; US government shutdown, volatility of industry conditions could impact demand for its services; a reduction in the availability of credit could reduce demand for Dexterra's products and services; Dexterra's significant shareholder may substantially influence its direction and operations and its interests may not align with other shareholders; its significant shareholder's approximate

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/286110